Why Vertex’s and CRISPR Therapeutics’ Stocks Are Rallying
June 7, 2019
0
Vertex and CRISPR Therapeutics While some groups are doubting the gene editing capability of CRISPR gene editing Vertex’s (VRTX) scientists enjoyed what they experienced during their clinical collaboration with CRISPR Therapeutics (